| Sign In to gain access to subscriptions and/or personal tools. |
DOI: 10.1177/0883073807307099 Identification of a Novel DHCR7 Mutation in a Korean Patient With Smith-Lemli-Opitz SyndromeDepartment of Pediatrics, Seoul National University College of Medicine, Seoul, Korea
Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea, pednr{at}plaza.snu.ac.kr
Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea
Department of Laboratory Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Department of Laboratory Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Smith-Lemli-Opitz syndrome is a unique malformation syndrome characterized by a defect in cholesterol biosynthesis, which is very rare among populations in Middle and East Asia. The authors identified compound heterozygous mutations ([p.Arg352Trp] + [p.Lys376ArgfsX37]) in a Korean girl with clinical and laboratory features typical of Smith-Lemli-Opitz syndrome. The Lys376ArgfsX37 mutation is a novel mutation, and to the best of the authors' knowledge, this is the first report of a clinically and genetically confirmed case of Smith-Lemli-Opitz syndrome in Korea.
Key Words: Smith-Lemli-Opitz syndrome DHCR 7 gene
|